AFESEF-CV-500
Description_Effects
AFESEF-CV-500 is a powerful antibiotic combination containing Cefuroxime and Clavulanic Acid, used to treat a wide range of bacterial infections. Cefuroxime is a second-generation cephalosporin antibiotic that works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to the death of the bacteria. It is effective against various gram-positive and gram-negative organisms. However, some bacteria can develop resistance to Cefuroxime by producing enzymes called beta-lactamases, which degrade the antibiotic and make it ineffective. Clavulanic Acid is added to the formulation to counter this problem. It is a beta-lactamase inhibitor that works by blocking the activity of these bacterial enzymes, thereby protecting Cefuroxime from degradation and enhancing its antibacterial efficacy. AFESEF-CV-500 is commonly prescribed for infections of the respiratory tract such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and certain types of ear, nose, and throat infections. This combination therapy is particularly helpful in cases where resistance to standard antibiotics is suspected or known. The medication should be taken as directed by a healthcare provider, usually after food to improve absorption and minimize gastric upset. Completing the full course of the antibiotic is essential to prevent the development of further resistance and to ensure complete eradication of the infection.
